Practitioner Diversion Awareness Conference
July 22, 2019 04:00 am - July 23, 2019 01:00 pm
The Drug Enforcement Administration (DEA) will be hosting two regional one-day Practitioner Diversion Awareness Conferences (PDAC) on Monday, July 22, and Tuesday, July 23, 2019. The same conference will be held both days. Participants can attend either day. The conferences will be held at the Indianapolis Marriott East, Indianapolis, IN 46219.
The diversion of pharmaceutical controlled substances throughout the United States is a growing problem. This diversion stems from various sources. In addition to pharmacy robberies and thefts, pharmaceutical controlled substances are often diverted by way of forged prescriptions, doctor shoppers, or illegitimate prescriptions from rogue practitioners. The PDAC is designed to assist DEA registered Practitioners (e.g. doctors, veterinarians, dentists, physician assistants, and nurse practitioners) in identifying and preventing diversion activity.
There is no registration fee for these conferences. However, attendees will be responsible for their own transportation, lodging, and meal expenses. Information about nearby restaurants will be provided at the conference.
If you wish to reserve a room at the hotel, you can call the hotel directly at (317)-352-1231.
The closest airport is the Indianapolis International Airport (IND), which is 21 miles from the hotel. The hotel does not offer transportation. Alternate options: Carey Indiana Limousine Service: $32.76 one-way; reservation required, Uber/Lyft, and/or Taxi. Self-parking is available every day. Valet parking is not available.
Each one-day conference will be held in the Liberty Hall, located on the first floor, from 8:00 a.m. to 5:00 p.m. each day. You must check in with DEA personnel before the start of the conference. Conference check-in will be from 7:00 a.m. to 8:00 a.m. each day outside of the ballroom.
NOTE: You must be a DEA registered Practitioner (e.g. doctor, veterinarian, dentist, physician assistant, and/or nurse practitioner) in the state of Indiana in order to attend this conference.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the United States Drug Enforcement Administration. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.
The Federation of State Medical Boards designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Seating is limited at these conferences and it is recommended you register as early as possible.